Wells Fargo Downgrades Olin (NYSE: OLN) Amidst Challenging Quarterly Performance
Wells Fargo adjusted its rating for Olin (NYSE: OLN) to Equal Weight, setting a new price target of $20.00 . Olin reported a challenging quarter, missing analyst expectations with a loss of $0.12 per share and sales of $1.70 billion . Despite a significant increase in net loss ,
- Wells Fargo adjusted its rating for Olin (NYSE: OLN) to Equal Weight, setting a new price target of $20.00.
- Olin reported a challenging quarter, missing analyst expectations with a loss of $0.12 per share and sales of $1.70 billion.
- Despite a significant increase in net loss, Olin saw an improvement in adjusted EBITDA to $191.30 million, indicating mixed operational results.
On August 3rd, 2026, Wells Fargo changed its rating for Olin (NYSE: OLN) to Equal Weight. Olin, a manufacturer of chemical products and ammunition, received a new price target of $20.00. This suggests a potential 7.41% upside from its price of $18.62 at the time of the announcement.
The downgrade follows a challenging quarterly earnings report for Olin. The company reported a loss of $0.12 per share, significantly missing analyst forecasts that predicted a profit of $0.12 per share. As highlighted by The Motley Fool, sales of $1.70 billion also fell short of the expected $1.80 billion, causing the stock to drop 17.8%.
Financially, Olin's net loss increased significantly. As announced by PR Newswire, the company reported a net loss of $13.30 million for the second quarter. This represents a large increase from the $1.30 million net loss reported in the same quarter of the previous year, clearly showing a decline in overall profitability.
The company's financial performance was mixed across its business segments. Sales in its Chlor Alkali Products and Vinyls division fell by 14%. This decline was partly balanced by a 27% increase in Epoxy sales and a 12% growth in its Winchester ammunition business, illustrating uneven results across its operations.
Despite the net loss, Olin's adjusted EBITDA improved to $191.30 million from $176.10 million last year. Adjusted EBITDA is a key measure of operational profit. The company faced an unplanned outage at its Freeport facility and persistent supply-chain issues, which created a volatile environment for its chemical business.
Originally published by fmp.
View original article